Profil
Tobias Larsson Agervald is Chief Executive Officer at Guard Therapeutics International AB since 2019 and Director at TE Medical Consulting AB since 2018.
Former roles include Senior Medical Director at Astellas Pharma Global Development, Inc. and Associate Professor at Karolinska Institutet.
Education includes doctorates from the University of Uppsala and Harvard Medical School.
Aktive Positionen von Tobias Larsson Agervald
| Unternehmen | Position | Beginn |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Vorstandsvorsitzender | 15.01.2019 |
TE Medical Consulting AB | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Tobias Larsson Agervald
| Unternehmen | Position | Ende |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Tobias Larsson Agervald
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
TE Medical Consulting AB |
















